We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pain-Free Breast Imaging System Performs One Minute Cancer Scan

By HospiMedica International staff writers
Posted on 11 Jul 2025

Breast cancer is one of the leading causes of death for women worldwide, and early detection is key to improving outcomes. More...

Traditional methods like mammograms and ultrasound have their limitations, particularly for women with dense breast tissue, where mammography is less effective. Ultrasound, while better for dense tissue, is operator-dependent and prone to false positives. Moreover, these techniques can be uncomfortable and painful for patients. To address these issues, researchers have now developed a pain-free imaging system that combines photoacoustic imaging and ultrasound to deliver clearer and more accurate 3D images of breast cancer, thus significantly improving early diagnosis and reducing false positives.

The OneTouch-PAT pain-free breast imaging system, created by researchers from the University at Buffalo (Buffalo, NY, USA), combines photoacoustic imaging, which uses laser pulses to detect blood vessel growth in tumors, with ultrasound imaging, which identifies suspicious lesions. Unlike previous systems, OneTouch-PAT integrates both imaging techniques in a fully automated process, eliminating operator error. The device automatically performs the photoacoustic scan followed by an ultrasound scan, repeating this pattern until the entire breast is covered. The data is then processed using AI algorithms to produce clear, detailed 3D images in just minutes.

In trials with 61 breast cancer patients and 4 healthy individuals, OneTouch-PAT demonstrated superior accuracy in identifying breast cancer subtypes, including Luminal A, Luminal B, and Triple-Negative Breast Cancer. The results, published in Nature Communications, showed that the system accurately detected tumor-associated blood vessels and provided detailed vascular patterns associated with each cancer subtype. Researchers now plan further studies to expand its use, refine data extraction methods, and improve the system’s capabilities. The technology holds great promise, especially for women with dense breast tissue, and could be a valuable addition to existing breast cancer screening methods that are often uncomfortable and painful.

“Our system, which is called OneTouch-PAT, combines advanced imaging, automation, and artificial intelligence—all while enhancing patient comfort,” said Jun Xia, PhD, the corresponding author of the study. “More work is needed before it can be used in clinical settings, but we’re excited about OneTouch-PAT’s potential to augment current imaging methods and help fight this terrible disease.”

Related Links:
University at Buffalo


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gas Analyzer
GE SAM
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.